Literature DB >> 23892187

Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.

T A Middelburg1, H S de Bruijn, L Tettero, A van der Ploeg van den Heuvel, H A M Neumann, E R M de Haas, D J Robinson.   

Abstract

Vascular responses to photodynamic therapy (PDT) may influence the availability of oxygen during PDT and the extent of tumor destruction after PDT. However, for topical PDT vascular effects are largely unknown. Arteriole and venule diameters were measured before and after hexylaminolevulinate (HAL) and aminolevulinic acid (ALA) PDT and related to the protoporphyrin IX (PpIX) concentration in the vessel wall. A mouse skin fold chamber model and an intravital confocal microscope allowed direct imaging of the subcutaneous vessels underlying the treated area. In both HAL and ALA groups over 60% of arterioles constricted completely, while venules generally did not respond, except for two larger veins that constricted partially. Arteriole vasoconstriction strongly correlated with PpIX fluorescence intensity in the arteriole wall. Total PpIX fluorescence intensity was significantly higher for HAL than ALA for the whole area that was imaged but not for the arteriole walls. In conclusion, complete arteriole vasoconstriction occurs frequently in both HAL and ALA based topical PDT, especially when relatively high PpIX concentrations in arteriole walls are reached. Vasoconstriction will likely influence PDT effect and should be considered in studies on topical HAL and ALA-PDT. Also, our results may redefine the vasculature as a potential secondary target for topical PDT.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALA; HAL; PDT; PpIX distribution; Vascular effect; Vasoconstriction

Mesh:

Substances:

Year:  2013        PMID: 23892187     DOI: 10.1016/j.jphotobiol.2013.06.014

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

2.  Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Authors:  Flávia Cristina Perillo Rosin; Ana Rita Ribeiro Barcessat; Giuliana Gadoni Giovanni Borges; Luciana Gonçalves Valente Ferreira; Luciana Corrêa
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

3.  Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy.

Authors:  Shannon M Gallagher-Colombo; Harry Quon; Kelly M Malloy; Peter H Ahn; Keith A Cengel; Charles B Simone; Ara A Chalian; Bert W O'Malley; Gregory S Weinstein; Timothy C Zhu; Mary E Putt; Jarod C Finlay; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2015-07-02       Impact factor: 3.421

4.  Automatic protocol for quantifying the vasoconstriction in blood vessel images.

Authors:  Xuelin Xu; Lisheng Lin; Buhong Li
Journal:  Biomed Opt Express       Date:  2020-03-20       Impact factor: 3.732

5.  Assessment of the In Vivo Response to Nanobody-Targeted PDT Through Intravital Microscopy.

Authors:  Henriette S de Bruijn; Ann L B Seynhaeve; Timo L M Ten Hagen; Sabrina Oliveira; Dominic J Robinson
Journal:  Methods Mol Biol       Date:  2022

Review 6.  A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.

Authors:  Wei Yu; Jian Zhu; Yitian Wang; Junjie Wang; Weijing Fang; Kaishun Xia; Jianlin Shao; Minzu Wu; Bing Liu; Chengzhen Liang; Chengyi Ye; Huimin Tao
Journal:  Oncotarget       Date:  2017-06-13

7.  Porphyria and kidney diseases.

Authors:  Nicolas Pallet; Alexandre Karras; Eric Thervet; Laurent Gouya; Zoubida Karim; Hervé Puy
Journal:  Clin Kidney J       Date:  2018-01-10

8.  Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.

Authors:  Henriette S de Bruijn; Vida Mashayekhi; Tom J L Schreurs; Pieter B A A van Driel; Gustav J Strijkers; Paul J van Diest; Clemens W G M Lowik; Ann L B Seynhaeve; Timo L M Ten Hagen; Jeanine J Prompers; Paul M P van Bergen En Henegouwen; Dominic J Robinson; Sabrina Oliveira
Journal:  Theranostics       Date:  2020-01-20       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.